CD44 and breast cancer: Consistently, the MCF7 luminal BC cell line has a low percentage (0.7–1.4%) of BCSCs, while the MDA-MB-231 TNBC cell line exhibits low or null CD24 expression and high percentage (more than 90%) of CD44+ cells [14].